News05/12/2023
TrialSpark adopts Formation Bio brand
Formation Bio, Inc. →TrialSpark announced it would do business as Formation Bio from December 5, 2023. The company described its progression from recruitment and site-management software to running trials as a CRO and then acquiring and developing its own medicines. Its new identity reflected an established pipeline of majority-owned assets. The announcement anticipated a gradual back-end transition during 2024, so legacy TrialSpark references could remain in software, documents and billing. This is evidence of the commercial rebrand, not an asserted statutory name-amendment date.